What is the long-term trend for Artivion's contingent consideration fair value adjustments?

Over 3 years (2021 to 2025), Artivion's contingent consideration fair value adjustments has grown at a -4.6% compound annual growth rate (CAGR), from $8.87M to $7.7M.

Artivion AORT Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston ScientificBSX

-$30M-700%

Merit Medical SystemsMMSI

——

IAR

Integra LifeSciencesIART

——

TFX

TeleflexTFX

——

Globus MedicalGMED

——

Sana BiotechnologySANA

——

Other financials

Income statement

See full

Revenue$116.3M+17.5%

Gross profit$75.4M+18.7%

Operating income$5.8M+170%

Net income$1.4M+381%

EPS (diluted)$0.03+400%

Balance sheet

See full

Cash & equivalents$55.8M+47.9%

Total debt$258.2M-28.8%

Total equity$450.5M+53.1%

Total assets$883.2M+11.6%

Cash flow

See full

Operating cash flow$1.2M+107%

CapEx$8.0M+120%

Free cash flow-$6.8M+66.7%

Valuation

See full

Market cap$1.07B-24.8%

Enterprise value$1.27B-27.2%

P/E91.5×—

P/S2.3×-1.3×

Profitability

See full

Gross margin64.6%+0.6pp

Operating margin8.2%+4.1pp

Net margin2.5%+1.5pp

FCF margin-0.1%-2.5pp

Returns & leverage

See full

Return on equity3.1%+1.8pp

Debt / equity0.6×-0.7×

Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artivion's contingent consideration fair value adjustments?: Artivion (AORT) reported contingent consideration fair value adjustments of $1.74M in Q1 2026.
How has Artivion's contingent consideration fair value adjustments changed year-over-year?: Artivion's contingent consideration fair value adjustments increased by 161.5% year-over-year, from -$2.83M to $1.74M.
What is the long-term trend for Artivion's contingent consideration fair value adjustments?: Over 3 years (2021 to 2025), Artivion's contingent consideration fair value adjustments has grown at a -4.6% compound annual growth rate (CAGR), from $8.87M to $7.7M.